DEVELOPMENT OF POXVIRUS-BASED HTLV-I VACCINE CANDIDATES
IC Name
NATIONAL CANCER INSTITUTE
-
Activity
R01
-
Administering IC
CA
-
Application Type
5
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
-
Sub Project Total Cost
-
ARRA Funded
-
CFDA Code
393
-
Ed Inst. Type
-
Funding ICs
-
Funding Mechanism
-
Study Section
SRC
-
Study Section Name